ABEMACICLIB SECRETS

HR001 was discovered to own an efficacious reaction for people with relapsed/refractory non-Hodgkin lymphoma.Experimental: Dose expansion_sub-populace 2_lower dose of niraparib MTDs and/or applicant RP2Ds for elimusertib applied together with niraparib at a decreased preset dose.They may also task their cloaking effect on their surroundings, making